Detalles de la búsqueda
1.
Identification of a unique loss-of-function mutation in IGF1R and a crosstalk between IGF1R and Wnt/ß-catenin signaling pathways.
Biochim Biophys Acta Mol Cell Res
; 1865(6): 920-931, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29621572
2.
Analyzing the role of cannabinoids as modulators of Wnt/ß-catenin signaling pathway for their use in the management of neuropathic pain.
Bioorg Med Chem Lett
; 29(9): 1043-1046, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30871771
3.
Identification of a cross-talk between EGFR and Wnt/beta-catenin signaling pathways in HepG2 liver cancer cells.
Cell Signal
; 79: 109885, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33340661
4.
Analyzing structural differences between insulin receptor (IR) and IGF1R for designing small molecule allosteric inhibitors of IGF1R as novel anti-cancer agents.
Growth Horm IGF Res
; 55: 101343, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32877816
5.
p110α and p110ß isoforms of PI3K are involved in protection against H2O2 induced oxidative stress in cancer cells.
Breast Cancer
; 26(3): 378-385, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30499025
6.
Identification of dinactin, a macrolide antibiotic, as a natural product-based small molecule targeting Wnt/ß-catenin signaling pathway in cancer cells.
Cancer Chemother Pharmacol
; 84(3): 551-559, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31129716
7.
Corrigendum to "Identification of a cross-talk between EGFR and Wnt/beta-catenin signaling pathways in HepG2 liver cancer cells" [Cell Signal. 2021 Mar;79:109885].
Cell Signal
; 108: 110713, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37210797
Resultados
1 -
7
de 7
1
Próxima >
>>